Equities

Northwest Biotherapeutics Inc

Northwest Biotherapeutics Inc

Actions
  • Price (EUR)0.26
  • Today's Change0.032 / 14.04%
  • Shares traded33.80k
  • 1 Year change-67.09%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue1.931.681.01
OPERATING EXPENSES
Cost of revenue total------
Selling, general and admin. expenses, total303333
Depreciation/amortization------
Unusual expense(income)5.402.690.17
Other operating expenses, total------
Total operating expense637254
Operating income(61)(70)(53)
Other, net(2.02)--(0.65)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(63)(105)179
Provision for income taxes00--
Net income after taxes(63)(105)179
Minority interest------
Net income before extra. Items(63)(105)179
Total extraordinary items------
Net income(63)(105)179
Inc.avail. to common excl. extra. Items(64)(105)179
Inc.avail. to common incl. extra. Items(64)(105)179
EPS RECONCILIATION
Basic/primary weighted average shares1,1191,016874
Basic/primary eps excl. extra items(0.06)(0.1)0.21
Basic/primary eps incl. extra items(0.06)(0.1)0.21
Dilution adjustment------
Diluted weighted average shares1,1191,016874
Diluted eps excl. extra items(0.06)(0.1)0.21
Diluted eps incl. extra items(0.06)(0.1)0.21
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental5.246.075.01
SUPPLEMENTAL INCOME
Depreciation, supplemental1.531.300.32
Total special items5.402.690.17
NORMALISED INCOME
Normalized income before taxes(57)(102)179
Effect of special items on income taxes000
Income tax excluding impact of special items000
Normalized income after tax(57)(102)179
Normalized income avail. to common(59)(102)179
Basic normalized EPS(0.05)(0.1)0.21
Diluted normalized EPS(0.05)(0.1)0.21
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.